245 related articles for article (PubMed ID: 23145034)
1. Human α(2)β(1)(HI) CD133(+VE) epithelial prostate stem cells express low levels of active androgen receptor.
Williamson SC; Hepburn AC; Wilson L; Coffey K; Ryan-Munden CA; Pal D; Leung HY; Robson CN; Heer R
PLoS One; 2012; 7(11):e48944. PubMed ID: 23145034
[TBL] [Abstract][Full Text] [Related]
2. The role of androgen in determining differentiation and regulation of androgen receptor expression in the human prostatic epithelium transient amplifying population.
Heer R; Robson CN; Shenton BK; Leung HY
J Cell Physiol; 2007 Sep; 212(3):572-8. PubMed ID: 17541959
[TBL] [Abstract][Full Text] [Related]
3. Hunterian Lecture. Characterisation of human prostate epithelial progenitor differentiation in response to androgens.
Heer R
Ann R Coll Surg Engl; 2011 Sep; 93(6):424-8. PubMed ID: 21929909
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the stem cell marker CD133 is independent of promoter hypermethylation in human epithelial differentiation and cancer.
Pellacani D; Packer RJ; Frame FM; Oldridge EE; Berry PA; Labarthe MC; Stower MJ; Simms MS; Collins AT; Maitland NJ
Mol Cancer; 2011 Jul; 10():94. PubMed ID: 21801380
[TBL] [Abstract][Full Text] [Related]
5. Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens.
Miki J; Furusato B; Li H; Gu Y; Takahashi H; Egawa S; Sesterhenn IA; McLeod DG; Srivastava S; Rhim JS
Cancer Res; 2007 Apr; 67(7):3153-61. PubMed ID: 17409422
[TBL] [Abstract][Full Text] [Related]
6. The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells.
Vander Griend DJ; Karthaus WL; Dalrymple S; Meeker A; DeMarzo AM; Isaacs JT
Cancer Res; 2008 Dec; 68(23):9703-11. PubMed ID: 19047148
[TBL] [Abstract][Full Text] [Related]
7. Cancer stem-like cells in human prostate carcinoma cells DU145: the seeds of the cell line?
Wei C; Guomin W; Yujun L; Ruizhe Q
Cancer Biol Ther; 2007 May; 6(5):763-8. PubMed ID: 17592251
[TBL] [Abstract][Full Text] [Related]
8. Isolation, characterization and mobilization of prostate cancer tissue derived CD133+ MDR1+ cells.
Rentala S; Mangamoori LN
J Stem Cells; 2010; 5(2):75-81. PubMed ID: 22049617
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer stem cells: do they have a basal or luminal phenotype?
Maitland NJ; Frame FM; Polson ES; Lewis JL; Collins AT
Horm Cancer; 2011 Feb; 2(1):47-61. PubMed ID: 21761340
[TBL] [Abstract][Full Text] [Related]
10. Low-calcium serum-free defined medium selects for growth of normal prostatic epithelial stem cells.
Litvinov IV; Vander Griend DJ; Xu Y; Antony L; Dalrymple SL; Isaacs JT
Cancer Res; 2006 Sep; 66(17):8598-607. PubMed ID: 16951173
[TBL] [Abstract][Full Text] [Related]
11. The characterization of epithelial and stromal subsets of candidate stem/progenitor cells in the human adult prostate.
Ceder JA; Jansson L; Ehrnström RA; Rönnstrand L; Abrahamsson PA
Eur Urol; 2008 Mar; 53(3):524-31. PubMed ID: 18053634
[TBL] [Abstract][Full Text] [Related]
12. Human epithelial basal cells are cells of origin of prostate cancer, independent of CD133 status.
Taylor RA; Toivanen R; Frydenberg M; Pedersen J; Harewood L; ; Collins AT; Maitland NJ; Risbridger GP
Stem Cells; 2012 Jun; 30(6):1087-96. PubMed ID: 22593016
[TBL] [Abstract][Full Text] [Related]
13. Targeting the unique methylation pattern of androgen receptor (AR) promoter in prostate stem/progenitor cells with 5-aza-2'-deoxycytidine (5-AZA) leads to suppressed prostate tumorigenesis.
Tian J; Lee SO; Liang L; Luo J; Huang CK; Li L; Niu Y; Chang C
J Biol Chem; 2012 Nov; 287(47):39954-66. PubMed ID: 23012352
[TBL] [Abstract][Full Text] [Related]
14. Growth kinetics of CD133-positive prostate cancer cells.
Reyes EE; Kunovac SK; Duggan R; Kregel S; Vander Griend DJ
Prostate; 2013 May; 73(7):724-33. PubMed ID: 23138940
[TBL] [Abstract][Full Text] [Related]
15. Infiltrating bone marrow mesenchymal stem cells increase prostate cancer stem cell population and metastatic ability via secreting cytokines to suppress androgen receptor signaling.
Luo J; Ok Lee S; Liang L; Huang CK; Li L; Wen S; Chang C
Oncogene; 2014 May; 33(21):2768-78. PubMed ID: 23792449
[TBL] [Abstract][Full Text] [Related]
16. CD133, a novel marker for human prostatic epithelial stem cells.
Richardson GD; Robson CN; Lang SH; Neal DE; Maitland NJ; Collins AT
J Cell Sci; 2004 Jul; 117(Pt 16):3539-45. PubMed ID: 15226377
[TBL] [Abstract][Full Text] [Related]
17. CD133+ melanoma subpopulations contribute to perivascular niche morphogenesis and tumorigenicity through vasculogenic mimicry.
Lai CY; Schwartz BE; Hsu MY
Cancer Res; 2012 Oct; 72(19):5111-8. PubMed ID: 22865455
[TBL] [Abstract][Full Text] [Related]
18. CD133+ cancer stem cell-like cells derived from uterine carcinosarcoma (malignant mixed Müllerian tumor).
Choijamts B; Jimi S; Kondo T; Naganuma Y; Matsumoto T; Kuroki M; Iwasaki H; Emoto M
Stem Cells; 2011 Oct; 29(10):1485-95. PubMed ID: 21919130
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer resistance protein-mediated efflux of androgen in putative benign and malignant prostate stem cells.
Huss WJ; Gray DR; Greenberg NM; Mohler JL; Smith GJ
Cancer Res; 2005 Aug; 65(15):6640-50. PubMed ID: 16061644
[TBL] [Abstract][Full Text] [Related]
20. Progenitor cells are responsible for formation primary epithelial cultures in the prostate epithelial model.
Drewa T; Styczynski J
Int Urol Nephrol; 2007; 39(3):851-7. PubMed ID: 17318344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]